Clinical Assessment and Risk Stratification in Differentiated Thyroid Cancer

被引：21
作者：
Vaisman, Fernanda [1 ]
Tuttle, R. Michael [2 ]
机构：
[1] Inst Nacl Canc, Endocrinol Serv, Praca Cruz Vermelha 23,8 Andar, BR-20230130 Rio De Janeiro, RJ, Brazil
[2] Mem Sloan Kettering Canc Ctr, Dept Med, Endocrinol Serv, 1275 York Ave, New York, NY 10021 USA
来源：
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA | 2019年 / 48卷 / 01期
关键词：
Risk stratification; Thyroid cancer; Mortality; Recurrence; Response to therapy; AMERICAN JOINT COMMITTEE; 8TH EDITION; MANAGEMENT GUIDELINES; STAGING SYSTEMS; PAPILLARY; THERAPY; CLASSIFICATION; ASSOCIATION; CARCINOMA; OUTCOMES;
D O I：
10.1016/j.ecl.2018.11.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Thyroid cancer management is rapidly evolving to a personalized management approach. Risk stratification systems are designed to assist in personalized management. Differentiating patients who may benefit from aggressive therapy and intense follow-up as opposed to those who can be successfully treated with minimalized initial management options and follow-up is crucial to the development of the right treatment plan for the right patient in order to optimize initial therapy and follow-up testing. This article aims to describe and discuss the risk stratification systems currently recommended for differentiated thyroid cancer.
引用
收藏
页码：99 / +
页数：11
相关论文
共 35 条
[1]  
Brierley JD, 1997, CANCER, V79, P2414
[2]   Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients [J].
Castagna, Maria Grazia ;
Maino, Fabio ;
Cipri, Claudia ;
Belardini, Valentina ;
Theodoropoulou, Alexandra ;
Cevenini, Gabriele ;
Pacini, Furio .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 165 (03) :441-446
[3]   Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer [J].
Cooper, David S. ;
Doherty, Gerard M. ;
Haugen, Bryan R. ;
Kloos, Richard T. ;
Lee, Stephanie L. ;
Mandel, Susan J. ;
Mazzaferri, Ernest L. ;
McIver, Bryan ;
Pacini, Furio ;
Schlumberger, Martin ;
Sherman, Steven I. ;
Steward, David L. ;
Tuttle, R. Michael .
THYROID, 2009, 19 (11) :1167-1214
[4]   Clinical and Pathological Factors Related to 18F-FDG-PET Positivity in the Diagnosis of Recurrence and/or Metastasis in Patients with Differentiated Thyroid Cancer [J].
Esteva, D. ;
Muros, M. A. ;
Llamas-Elvira, J. M. ;
Jimenez Alonso, J. ;
Villar, J. M. ;
Lopez de la Torre, M. ;
Muros, T. .
ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (07) :2006-2013
[5]   Using the American Thyroid Association Risk-Stratification System to Refine and Individualize the American Joint Committee on Cancer Eighth Edition Disease-Specific Survival Estimates in Differentiated Thyroid Cancer [J].
Ghaznavi, Sana A. ;
Ganly, Ian ;
Shaha, Ashok R. ;
English, Crystal ;
Wills, Jonathan ;
Tuttle, R. Michael .
THYROID, 2018, 28 (10) :1293-1300
[6]   2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer [J].
Haugen, Bryan R. ;
Alexander, Erik K. ;
Bible, Keith C. ;
Doherty, Gerard M. ;
Mandel, Susan J. ;
Nikiforov, Yuri E. ;
Pacini, Furio ;
Randolph, Gregory W. ;
Sawka, Anna M. ;
Schlumberger, Martin ;
Schuff, Kathryn G. ;
Sherman, Steven I. ;
Sosa, Julie Ann ;
Steward, David L. ;
Tuttle, R. Michael ;
Wartofsky, Leonard .
THYROID, 2016, 26 (01) :1-133
[7]  
Kim K., 2018, World J Surg
[8]   Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma [J].
Kim, Tae Hyuk ;
Kim, Young Nam ;
Kim, Hye In ;
Park, So Young ;
Choe, Jun-Ho ;
Kim, Jung-Han ;
Kim, Jee Soo ;
Oh, Young Lyun ;
Hahn, Soo Yeon ;
Shin, Jung Hee ;
Kim, Kyunga ;
Jeong, Jong Gill ;
Kim, Sun Wook ;
Chung, Jae Hoon .
ORAL ONCOLOGY, 2017, 71 :81-86
[9]  
Leboulleux S, 2001, THYROID, V11, P1169
[10]   Mortality Risk Stratification by Combining BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Cancer Genetic Duet of BRAF and TERT Promoter Mutations in Thyroid Cancer Mortality [J].
Liu, Rengyun ;
Bishop, Justin ;
Zhu, Guangwu ;
Zhang, Tao ;
Ladenson, Paul W. ;
Xing, Mingzhao .
JAMA ONCOLOGY, 2017, 3 (02) :202-208
1234